Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Papo

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|June 19, 2026
Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levelsJerome Razanamahery, Matthias Papo, Francesco Pegoraro, et al.
RMD Open|April 9, 2026
Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patientsCarine Schmidt, Matthias Papo, Dov Taïeb, et al.
RMD Open|March 13, 2026
Hyposplenism in systemic lupus erythematosus: biological and radiological characteristics and its association with increased risk of infectionLudovic Trefond, Alexis Mathian, Samia Boussouar, et al.
Lupus|July 1, 2025
Performance of SCORE2, QRISK3 and PREVENT equations in systemic lupus erythematosusLévi-Dan Azoulay, Thomas Broussaud, Nadjia Kachenoura, et al.
Rheumatology (Oxford, England)|April 9, 2025
Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre studyMathilde Katims, Marc Pineton de Chambrun, Cecile Yelnik, et al.
Rheumatology (Oxford, England)|October 29, 2024
Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patientsMatthias Papo, Pierre Cappy, Alexandre Degachi, et al.
Atherosclerosis|November 6, 2025
Assessment of the 2025 EAS clinical staging system for cardiometabolic disorders in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Joint Bone Spine|July 4, 2024
Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawalLudovic Trefond, Alexis Mathian, Raphael Lhote, et al.
Seminars in Arthritis and Rheumatism|February 23, 2024
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patientsLudovic Trefond, Raphael Lhote, Alexis Mathian, et al.
Leukemia|August 21, 2025
Unraveling the molecular landscape of Erdheim-Chester disease: new insights from methylome and transcriptome integrationMiriam Cerván-Martín, Francesco Pegoraro, Javier Martínez-López, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|June 19, 2026
Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levelsJerome Razanamahery, Matthias Papo, Francesco Pegoraro, et al.
RMD Open|April 9, 2026
Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patientsCarine Schmidt, Matthias Papo, Dov Taïeb, et al.
RMD Open|March 13, 2026
Hyposplenism in systemic lupus erythematosus: biological and radiological characteristics and its association with increased risk of infectionLudovic Trefond, Alexis Mathian, Samia Boussouar, et al.
Lupus|July 1, 2025
Performance of SCORE2, QRISK3 and PREVENT equations in systemic lupus erythematosusLévi-Dan Azoulay, Thomas Broussaud, Nadjia Kachenoura, et al.
Rheumatology (Oxford, England)|April 9, 2025
Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre studyMathilde Katims, Marc Pineton de Chambrun, Cecile Yelnik, et al.
Rheumatology (Oxford, England)|October 29, 2024
Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patientsMatthias Papo, Pierre Cappy, Alexandre Degachi, et al.
Atherosclerosis|November 6, 2025
Assessment of the 2025 EAS clinical staging system for cardiometabolic disorders in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Joint Bone Spine|July 4, 2024
Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawalLudovic Trefond, Alexis Mathian, Raphael Lhote, et al.
Seminars in Arthritis and Rheumatism|February 23, 2024
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patientsLudovic Trefond, Raphael Lhote, Alexis Mathian, et al.
Leukemia|August 21, 2025
Unraveling the molecular landscape of Erdheim-Chester disease: new insights from methylome and transcriptome integrationMiriam Cerván-Martín, Francesco Pegoraro, Javier Martínez-López, et al.
Pageof 4